6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Cardiovascular Regenerative Medicine
The advancements in cardiovascular regenerative medicine are reshaping therapeutic strategies for heart diseases by promoting tissue repair and regeneration. This innovative field leverages technologies such as induced pluripotent stem cells and growth factor delivery to restore the heart’s structural and functional integrity. Bioengineered scaffolds and 3D bioprinting are also being utilized to reconstruct damaged myocardium and improve vascularization. Researchers are further exploring the role of exosomes and microRNAs in enhancing the heart’s natural regenerative processes. With ongoing clinical trials and interdisciplinary collaboration, cardiovascular regenerative medicine holds immense potential to provide long-term solutions for conditions like ischemic heart disease and heart failure, moving beyond traditional treatments toward curative approaches.
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Arthur J Siegel
Massachusetts General Hospital, United States
Abraham Teddy Weiss
Hadassah University Hospital, Israel
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Iris Panagiota Efthymiou
University of Greenwich, United KingdomSubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom